04/05/2026
Around 1 in 10 women of reproductive age are affected by Endometriosis, underscoring the need for improved diagnosis and care.
Recently our Pharmaceutical division hosted a scientific program in Lahore titled “Relief Made Visible,” bringing together over 100 healthcare professionals to advance better outcomes for women silently living with this condition.
The session focused on current gaps in clinical practice and evolving approaches to management, including the role of targeted hormonal therapy in enabling more patient-centric care. Interactive case discussions further contributed to practical, experience-driven insights, which we hope to see translate into improved patient care.
Women's health is in Bayer's DNA and we remain committed to advancing awareness, diagnosis, and management of endometriosis for the women in Pakistan.